Advance Search
ZHU Duanrong, LI Fangyuan, DAI Wen, WU Feifei, WANG Weiqing. Observation in effect of loop electrosurgical excision procedure combined with recombinant human interferon α2b vaginal effervescent capsules in the treatment of cervical intraepithelial neoplasia[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 109-113. DOI: 10.7619/jcmp.20210986
Citation: ZHU Duanrong, LI Fangyuan, DAI Wen, WU Feifei, WANG Weiqing. Observation in effect of loop electrosurgical excision procedure combined with recombinant human interferon α2b vaginal effervescent capsules in the treatment of cervical intraepithelial neoplasia[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 109-113. DOI: 10.7619/jcmp.20210986
shu

Observation in effect of loop electrosurgical excision procedure combined with recombinant human interferon α2b vaginal effervescent capsules in the treatment of cervical intraepithelial neoplasia

  • 1.

    Department of Obstetrics and Gynecology, General Hospital of the Eastern Theater Command, Nanjing, Jiangsu, 210000

  • 2.

    Department of Obstetrics and Gynecology, Air force Hospital of Eastern Theater Command, Nanjing, Jiangsu, 210000

  • 3.

    Department of Medical Laboratory, General Hospital of the Eastern Theater Command, Nanjing, Jiangsu, 210000

More Information
  • Received Date: March 08, 2021
  • Available Online: October 12, 2021
  • Published Date: September 14, 2021
    Graphical Abstract
    • Abstract
  •   Objective   To observe the clinical efficacy of loop electrosurgical excision procedure (LEEP) combined with recombinant human interferon α2b vaginal effervescent capsules in the treatment of cervical intraepithelial neoplasia (CIN).
      Methods   A total of 186 patients with CIN were selected as study objects, and were randomly divided into study group(n=93) and control group (n=93) according to random number table method. The control group was treated with LEEP, and the study group was treated with recombinant human interferon α2b vaginal effervescent capsules on the basis of the control group. The changes of immune function and operation indexes were observed before and after treatment, and the treatment effect, recurrence rate and complications were compared between the two groups.
      Results   The vaginal discharge volume of patients with CIN Ⅰ, Ⅱ and Ⅲ grade in the study group was less than that in the control group, and the wound healing time patients with CIN Ⅰ was shorter than that in the control group (P <0.05). Compared with the control group, the vaginal discharge volume of patients in the study group was less than that in the control group, vaginal discharge time and wound healing time of the study group were shorter than those in the control group (P <0.05). The levels of CD4+, CD4+/CD8+ in the study group after treatment were higher than those in the control group, and the level of CD8+ in the study group was lower than that in the control group (P <0.05). Compared with the control group, the levels of C-reactive protein (CRP) and tumor necrosis factor-α(TNF-α) in the study group were lower, and the level of IL-10 was higher (P <0.05). The total effective rate of the study group was significantly higher than that of the control group (93.55% versus 79.57%, P <0.05), and the postoperative recurrence rate was significantly lower than that of thecontrol group (2.15% versus 13.98%, P <0.05). There was no significant difference in the total incidence of perioperative complications between the two groups (P >0.05).
      Conclusion   LEEP combined with recombinant human interferon α2b vaginal effervescent capsules in the treatment of CIN can effectively regulate the immune function, improve the clinical efficacy and reduce the risk of postoperative recurrence.
    • FullText(HTML)
    • References (16)
  • [1]
    王则绯, 暴蕾, 谭宏伟. 宫颈环形电切术治疗高级别鳞状上皮内病变的临床效果及对患者妊娠结局的影响[J]. 实用临床医药杂志, 2019, 23(21): 43-47. doi: 10.7619/jcmp.201921013
    [2]
    张博, 马晓黎, 孟戈. LEEP术对绝经后妇女高级别宫颈上皮内瘤变的诊治[J]. 国际妇产科学杂志, 2020, 47(1): 33-36. doi: 10.3969/j.issn.1674-1870.2020.01.007
    [3]
    曹泽毅. 中华妇产科学-上册[M]. 3版. 北京: 人民卫生出版社, 2014: 67-77.
    [4]
    中华人民共和国国家卫生和计划生育委员会. 宫颈癌及癌前病变规范化诊疗指南(试行)[J]. 中国医学前沿杂志: 电子版, 2013, 5(8): 37-46. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201308012.htm
    [5]
    武彩霞. 阴道镜辅助下LEEP刀手术治疗宫颈癌前病变的效果[J]. 临床医学研究与实践, 2020, 5(11): 92-93. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS202011041.htm
    [6]
    陈丽梅, 刘莉, 陶祥, 等. 1005例子宫颈HSIL患者行LEEP术后24个月内的复发及其影响因素分析[J]. 中华妇产科杂志, 2019, 54(8): 534-540. doi: 10.3760/cma.j.issn.0529-567x.2019.08.006
    [7]
    徐燕, 陈诚, 任玉香, 等. CIN患者LEEP术后复发的预测列线图的构建及验证[J]. 广西医科大学学报, 2020, 37(2): 282-286. https://www.cnki.com.cn/Article/CJFDTOTAL-GXYD202002027.htm
    [8]
    杜祯, 陈锡山, 盛赠美. 宫颈癌及宫颈上皮内瘤变患者宫颈液基薄层细胞学检查及高危型人乳头瘤病毒检测的临床价值[J]. 实用临床医药杂志, 2020, 24(17): 24-27. doi: 10.7619/jcmp.202017006
    [9]
    高清滢, 侯洁心. 高频电波刀宫颈电环切除术治疗中重度宫颈柱状上皮异位临床疗效研究[J]. 陕西医学杂志, 2019, 48(2): 223-226. doi: 10.3969/j.issn.1000-7377.2019.02.023
    [10]
    ATEMNKENG N, AJI A D, DE SANJOSE S, et al. Antiretroviral therapy and detection of high-grade cervical intraepithelial neoplasia (CIN2+) at post-CIN management follow-up among women living with human immunodeficiency virus: a systematic review and meta-analysis[J]. Clin Infect Dis, 2020, 71(10): e540-e548. doi: 10.1093/cid/ciaa238
    [11]
    亮亮, 咱呷拉姆, 四郎青措. 宫颈环形电切术联合干扰素栓治疗宫颈上皮内瘤变的临床疗效[J]. 医学临床研究, 2019, 36(4): 681-683. doi: 10.3969/j.issn.1671-7171.2019.04.020
    [12]
    弋文娟, 蒋洪昆, 陈煜岊, 等. 膦甲酸钠联合重组人干扰素用于高级别宫颈上皮内瘤变伴高危型HPV感染患者宫颈环形电切术后临床研究[J]. 中国性科学, 2019, 28(12): 125-129. https://www.cnki.com.cn/Article/CJFDTOTAL-XKXZ201912035.htm
    [13]
    张佳珍. LEEP术后干扰素凝胶联合保妇康栓对CIN Ⅲ患者疗效及炎症因子水平的影响[J]. 中国计划生育学杂志, 2019, 27(5): 608-611. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY201905016.htm
    [14]
    谢秀梅, 徐芳. LEEP刀宫颈锥切术联合重组α-2b干扰素栓治疗宫颈上皮内瘤变疗效观察[J]. 海南医学, 2019, 30(3): 339-341. doi: 10.3969/j.issn.1003-6350.2019.03.021
    [15]
    李寅红, 刘铭兰, 季滢. LEEP联合干扰素对宫颈上皮内瘤变患者免疫功能和高危型HPV-DNA表达的影响[J]. 医学临床研究, 2019, 28(10): 2061-2062. doi: 10.3969/j.issn.1671-7171.2019.10.071
    [16]
    崔开颖, 朱根海, 杨舒盈, 等. 重组干扰素联合抗生素对宫颈上皮内瘤变LEEP术后HPV-DNA负荷量及caspase-3、survivin表达的影响[J]. 疑难病杂志, 2020, 19(1): 61-65. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ202001016.htm
    • Related Articles

  • Related Articles

    [1]GU Xin, JING Liwei, WANG Andi, LIU Jun, DAI Yongqiang, ZHANG Baoling. Analysis of the recurrence rate and risk factors of renal calculi after intracavitary lithotripsy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 39-41. DOI: 10.7619/jcmp.20232864
    [2]LIU Haijia, CHEN Ming, LI Yanzhen. Analysis in risk factors of postoperative recurrence of patients with refractory epilepsy and establishment of a risk prediction model[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 7-11. DOI: 10.7619/jcmp.20240080
    [3]SHEN Bingyan, SHEN Qian, XU Lingling. Influence factors for recurrence of cytoreductive surgery in patients with epithelial ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 14-18. DOI: 10.7619/jcmp.20231817
    [4]CHEN Chunyu, ZHOU Jing, LIU Guyue, YU Jie, GU Jiangkui. Construction and validation of a Nomogram model for postoperative early recurrence in patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 7-13. DOI: 10.7619/jcmp.20232467
    [5]XUE Huimin, CHEN Tao, ZHU Xiaojun. Analysis of postoperative recurrence and risk factors of patients with liver cancer after radical resection[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 35-38. DOI: 10.7619/jcmp.20221356
    [6]GENG Suhong, WANG Weina, WANG Xiaona. Efficacy of rituximab combined with conventional chemotherapy in treating patients with diffuse large B-cell lymphoma and influencing factors of recurrence[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 93-97. DOI: 10.7619/jcmp.20213295
    [7]DONG Yanping, WANG Jiemin, WANG Yujin, REN Yali, DONG Yucheng, YONG Yanjun, SU Xuandi, WANG Jixiang, SU Nan, WANG Fuli, XIA Duosheng. Construction and evaluation of Nomogram prediction model for postoperative recurrence of pterygium[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 52-56. DOI: 10.7619/jcmp.20214610
    [8]LING Yan. Nutritional risk and its influencing factors of severe neurosurgical patients[J]. Journal of Clinical Medicine in Practice, 2017, (10): 43-46. DOI: 10.7619/jcmp.201710014
    [9]YU Shuying. The effect of risk factors management nursing in reducing infection in operation room[J]. Journal of Clinical Medicine in Practice, 2015, (14): 93-95,109. DOI: 10.7619/jcmp.201514030
    [10]CHEN Jinghua, TANG Hui, YU Chuanhu, LI Wei. Research on recurrent situation and risk factors of endometrial cancer[J]. Journal of Clinical Medicine in Practice, 2013, (13): 145-147. DOI: 10.7619/jcmp.201313053

  • Cited by

    Periodical cited type(4)

    1. 殷华芳，沙莎，蔡依玲，于波，刘佳，何佳，孙玲娣，王坚. 宫颈癌放射治疗相关卵巢损伤的分子机制及防治策略研究进展. 实用临床医药杂志. 2024(10): 141-144 . 本站查看
    2. 张玉洲，李晓敏，孙少霖. 蓝萼乙素通过Akt/BAD通路对宫颈癌裸鼠移植瘤生长的影响. 现代药物与临床. 2024(06): 1384-1389 .
    3. 沈静，张丽华，徐晶晶，吕萌萌，吴东辰. 卡瑞利珠单抗联合白蛋白结合型紫杉醇对晚期宫颈癌患者肿瘤标志物、免疫功能和血管新生指标的影响. 现代生物医学进展. 2024(13): 2592-2595 .
    4. 曾美男. 早期宫颈癌术后不同治疗方法的临床效果分析. 实用妇科内分泌电子杂志. 2023(24): 28-30+85 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (241) PDF downloads (19) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return